Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

210 insider filings · Latest: Aug 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 15, 2025May 15 8:04 PMPAUL MAHON
Proposed Sale
11,000$295.10$3.2M

View →

May 9, 2025May 9 8:59 PMTOMMY THOMPSON
Proposed Sale
2,500$305.15$762.9K

View →

May 1, 2025May 1 8:04 PMPAUL MAHON
Proposed Sale
11,000$300.93$3.3M

View →

Apr 21, 2025Apr 21 8:00 PMRAYMOND DWEK
Proposed Sale
3,000$285.57$856.7K

View →

Apr 17, 2025Apr 17 8:00 PMPAUL MAHON
Proposed Sale
11,000$283.78$3.1M

View →

Apr 14, 2025Apr 14 8:02 PMRAYMOND DWEK
Proposed Sale
3,000$285.16$855.5K

View →

Apr 7, 2025Apr 7 8:01 PMRAYMOND DWEK
Proposed Sale
4,000$284.55$1.1M

View →

Apr 3, 2025Apr 3 8:01 PMPAUL MAHON
Proposed Sale
11,000$306.18$3.4M

View →

Mar 24, 2025Mar 24 8:47 PMTOMMY THOMPSON
Proposed Sale
2,500$318.80$797.0K

View →

Mar 19, 2025Mar 19 8:11 PMCHRISTOPHER PATUSKY
Proposed Sale
5,000$310.72$1.6M

View →

Mar 10, 2025Mar 10 8:23 PMMichael Benkowitz
Proposed Sale
1,679$315.91$530.4K

View →

Feb 28, 2025Feb 28 9:34 PMTOMMY THOMPSON
Proposed Sale
2,500$318.34$795.8K

View →

Feb 28, 2025Feb 28 9:26 PMRAYMOND KURZWEIL
Proposed Sale
15,000$317.01$4.8M

View →

Feb 10, 2025Feb 10 9:28 PMMichael Benkowitz
Proposed Sale
40,000$347.71$13.9M

View →

Jan 13, 2025Jan 13 9:30 PMMichael Benkowitz
Proposed Sale
40,000$364.97$14.6M

View →

Jan 10, 2025Jan 10 9:29 PMCHRISTOPHER PATUSKY
Proposed Sale
5,000$361.61$1.8M

View →

Dec 30, 2024Dec 30 9:08 PMNILDA MESA
Proposed Sale
255$355.77$90.7K

View →

Dec 18, 2024Dec 18 10:51 PMLOUIS W. SULLIVAN
Proposed Sale
26,209$373.28$9.8M

View →

Dec 16, 2024Dec 16 9:38 PMMichael Benkowitz
Proposed Sale
40,000$361.81$14.5M

View →

Nov 18, 2024Nov 18 10:04 PMMichael Benkowitz
Proposed Sale
40,000$363.25$14.5M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 5, 2026Mar 9 8:36 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03202,000(D)

View →

Mar 5, 2026Mar 5 9:37 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0333,500(D)

View →

Mar 4, 2026Mar 5 9:36 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03211,500(D)

View →

Mar 4, 2026Mar 5 9:36 PMRay KurzweilDirector
Option Exercise
4,910$101.800(D)

View →

Mar 4, 2026Mar 5 9:35 PMTommy G ThompsonDirector
Option Exercise
2,000$101.802,000(D)

View →

Mar 4, 2026Mar 5 9:34 PMChristopher CauseyDirector
Option Exercise
20$119.766,300(D)

View →

Mar 3, 2026Mar 5 9:33 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03221,000(D)

View →

Mar 2, 2026Mar 3 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03230,500(D)

View →

Mar 15, 2023Feb 26 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Grant/Award
66,551$217.508,895(D)

View →

Mar 15, 2023Feb 26 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Grant/Award
277,299$217.5037,080(D)

View →

Mar 15, 2023Feb 26 9:30 PMMichael BenkowitzPRESIDENT AND COO
Grant/Award
133,102$217.5017,790(D)

View →

Mar 15, 2023Feb 26 9:30 PMJames EdgemondCFO AND TREASURER
Grant/Award
77,648$217.5010,380(D)

View →

Feb 25, 2026Feb 25 9:31 PMChristopher CauseyDirector
Option Exercise
1,000$119.766,320(D)

View →

Feb 23, 2026Feb 24 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,440$146.030(I)

View →

Feb 19, 2026Feb 19 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0341,800(D)

View →

Feb 17, 2026Feb 18 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.035,065(I)

View →

Feb 9, 2026Feb 10 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0312,940(I)

View →

Feb 5, 2026Feb 5 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0350,100(D)

View →

Feb 2, 2026Feb 3 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0320,815(I)

View →

Jan 26, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0328,690(I)

View →